Cross-linking of low-molecular weight and high-molecular weight polysaccharides, preparation of injectable monophase hydrogels, polysaccharides and hydrogels obtained
A process for the crosslinking of at least one polymer selected from polysaccharides and derivatives thereof, which is carried out in an aqueous solvent by the action of an effective and non-excessive amount of at least one crosslinking agent, characterized in that it is carried out on a mixture containing at least one low-molecular weight polymer and at least one high-molecular weight polymer. A process for the preparation of an injectable monophase hydrogel of at least one crosslinked polymer selected from polysaccharides and derivatives thereof. Crosslinked polymers and injectable monophase hydrogels respectively obtainable by each of said processes.
1. An injectable polymeric composition prepared by a process comprising the steps of:
1) forming a mixture of a first hyaluronic acid salt having a first molecular weight of about 3×10 5 Da and a second hyaluronic acid salt having a second molecular weight of about 3×10 6 Da; and
2) cross-linking the mixture formed in step 1) in an aqueous solvent in the presence of an effective and non-excessive amount of at least one cross-linking agent; and wherein the mixture contains about 90% by weight of the first hyaluronic acid salt and about 10% by weight of the second hyaluronic acid salt.
2. The composition of claim 1 , wherein at least one of the first hyaluronic acid salt and second hyaluronic acid salt is selected from a sodium salt, a potassium salt, and mixtures thereof.
3. The composition of claim 1 , wherein the cross-linking agent is selected from epichlorohydrin, divinyl sulfone, 1,4-bis(2,3-epoxypropoxy) butane, 1,2-bis(2,3-epoxypropoxy)ethylene, 1-(2,3-epoxypropyl) -2,3-epoxycyclohexane, aldehydes, and mixtures thereof.
4. The composition of claim 3 , wherein the aldehydes are selected from formaldehyde, glutaraldehyde, crotonaldehyde, and mixtures thereof.
5. The composition of claim 1 , wherein the cross-linking agent is 1,4-butanediol diglycidyl ether (BDDE).
6. The composition of claim 1 , having a hyaluronic acid concentration of between 20 and 30 mg/g.
7. The composition of claim 1 having a hyaluronic acid concentration of between 10 and 40 mg/g.
8. The composition of claim 1 wherein the process further comprises the step of 3) formulating the mixture formed in step 2), into a solution buffered to a pH of between 6.5 and 7.5.
9. The composition of claim 8 , wherein the pH is between 7 and 7.4.
10. The composition of claim 8 , wherein the pH is between 7.1 and 7.3.
11. The composition of claim 1 wherein the degree of crosslinking in the mixture is between 4% and 50%.
12. The composition of claim 1 wherein the mixture has an intrinsic viscosity of less than 1900 ml/g.
13. The composition of claim 1 , wherein each of the first hyaluronic acid salt and second hyaluronic acid salt is a sodium salt.